Effect of genetic variation in microRNA binding site in WNT1-inducible signaling pathway protein 1 gene on oral squamous cell carcinoma susceptibility

PLoS One. 2017 Apr 20;12(4):e0176246. doi: 10.1371/journal.pone.0176246. eCollection 2017.

Abstract

Background: Oral squamous cell carcinoma (OSCC), which is the most common head and neck cancer, accounts for 1%-2% of all human malignancies and is characterized by poor prognosis and reduced survival rates. WNT1-inducible signaling pathway protein 1 (WISP1), a cysteine-rich protein belonging to the Cyr61, CTGF, Nov (CCN) family of matricellular proteins, has many developmental functions and may be involved in carcinogenesis. This study investigated WISP1 single-nucleotide polymorphisms (SNPs) to elucidate OSCC susceptibility and clinicopathologic characteristics.

Methodology/principal findings: Real-time polymerase chain reaction was used to analyze 6 SNPs of WISP1 in 900 OSCC patients and 1200 cancer-free controls. The results showed that WISP1 rs2929970 polymorphism carriers with at least one G allele were susceptible to OSCC. Moreover, compared with smokers, non-smoker patients with higher frequencies of WISP1 rs2929970 (AG + GG) variants had a late stage (stages III and IV) and a large tumor size. In addition, OSCC patients who were betel quid chewers and carried WISP1 rs16893344 (CT + TT) variants had a low risk of lymph node metastasis.

Conclusion: Our results demonstrate that a joint effect of WISP1 rs2929970 with smoking as well as WISP1 rs16893344 with betel nut chewing causally contributes to the occurrence of OSCC. WISP1 polymorphism may serve as a marker or a therapeutic target in OSCC.

MeSH terms

  • Binding Sites
  • CCN Intercellular Signaling Proteins / genetics*
  • CCN Intercellular Signaling Proteins / metabolism
  • Carcinoma, Squamous Cell / metabolism*
  • Female
  • Humans
  • Male
  • MicroRNAs / metabolism*
  • Middle Aged
  • Mouth Neoplasms / metabolism*
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins / metabolism
  • Signal Transduction

Substances

  • CCN Intercellular Signaling Proteins
  • CCN4 protein, human
  • MicroRNAs
  • Proto-Oncogene Proteins

Grants and funding

This study was supported by CSH-2017-E-001-Y2 from Chung Shan Medical University Hospital Taiwan, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.